Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyl-l-carnitine for Nerve Regeneration in Severe Carpal Tunnel Syndrome
NCT02141035Phase 3Completed
- Sponsor
- University of Alberta
- Start
- Sep 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetyl-l-carnitine in carpal tunnel syndrome (CTS), sponsored by University of Alberta. Started Sep 2015; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT02141035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02141035.